Condition

Type 2 Diabetes

Treatments and trials tagged Type 2 Diabetes, with the same country and access zoom as New Developments.

All New Developments

Type 2 Diabetes breakthroughs

All countriesUnited StatesCanadaUnited KingdomJapanChinaAustraliaSwitzerlandEuropean UnionNewestPatient Stories
FDA ApprovedUnited States

New Heart-Protection Use for Mounjaro in Type 2 Diabetes

Mounjaro (tirzepatide) — weekly shot for adults with type 2 diabetes that now also carries a labelled heart-protection use

FDA supplemental approval effective 27 August 2026 for a new use of Mounjaro (tirzepatide) injection — a once-weekly subcutaneous dual…

This is for adults with type 2 diabetes who are at high risk for heart attack, stroke, or cardiovascular…

Health Canada/FDA ApprovedUnited StatesCanadaJapanChinaAustraliaSwitzerlandEuropean Union

Once-Weekly Insulin Shot for Adults with Type 2 Diabetes

Awiqli (insulin icodec / insulin icodec-abae) — once-weekly basal insulin

The first labelled once-weekly basal insulin. The United States (FDA, 26 Mar 2026) labels it only for adults with type 2 diabetes as an adjunct to diet…

The first labelled once-weekly basal insulin. The United States (FDA, 26 Mar 2026) labels it only for…